End-of-life CareNCT06026241
Practice Analysis of Care, Paraclinical Exams and Treatments Received by Geriatric Patients Both During the Last Week and the Last 24 Hours of Their Lives.
An observational study of End-of-life Care, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.
Trial summary
End-of-life care is a core topic for geriatricians. One of the key aspects of end-of-life management is deciding when to discontinue active care measures (for example blood pressure monitoring, blood tests and X-rays) in favor of exclusive comfort care. Read more about this study
- Who is it for?
- Ages 75 years and older
- Conditions the study is for
- End-of-life Care
- What is being tested?
- Collecting data from the medical record
- How many people
- 100 participants
- Where
- 1 siteFrance
- Study dates
- 1 Mar 2024to 31 Dec 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 75 years and older
- All sexes
- No healthy volunteers
- Older adult
Study population: All patients over 75 years old who died in the geriatric short-stay departments of Saint-Etienne University Hospital
Who may be able to join
- All patients over 75 years old who died in a geriatric short-stay department at Saint-Etienne University Hospital.
Who cannot join
- Patients under 75 years old
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
CHU Saint-Etienne
Saint-Etienne
Ludovic LAFAIE, MD, (0)477127397 ext. +33, ludovic.lafaie@chu-st-etienne.fr
Solène VALETTE, resident, (0)670511373 ext. +33, solene.valette@hotmail.fr
About this study
End-of-life care is a core topic for geriatricians. One of the key aspects of end-of-life management is deciding when to discontinue active care measures (for example blood pressure monitoring, blood tests and X-rays) in favor of exclusive comfort care. In this retrospective observational study, the investigators looked at the care measures, treatments and paraclinical exams received by geriatric patients both one week and 24 hours before their death.
Read the detailed description
This analysis provides information on the differences in geriatric physicians' practices regarding the anticipation of the end of life, by showing on average when active care measures were stopped before death. Secondly, the investigators looked at patient criteria that could explain a prolongation of active care and a delay in the implementation of exclusive comfort care.
- Conditions
- End-of-life Care
- Being tested
- Collecting data from the medical record
- Keywords
- End of life care, Geriatric, Death
- Medical subject headings
- Death
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Collecting data from the medical recordOther
Patient's socio-demographic data (age, gender, residence), comorbidities, cause of death, date and frequency of care measures/treatments/paraclinical exams received before their death.
| Study group | Role | What they receive |
|---|---|---|
| Patients over 75 who died in geriatrics | Patients over 75 years old who died in the geriatric short-stay departments of Saint-Etienne University Hospital Receives: Other: Collecting data from the medical record |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of care and treatments received during the last week of life, and during the last 24 hours of life
To measure the prevalence of care (hemodynamic, biological and radiological monitoring), and to evaluate the treatments received during the last week of life, and during the last 24 hours of life of patients hospitalized and who died in a geriatric short-stay ward.
Measured: In the last week of life and 24 hours before death
Secondary outcomes (1)
Patient criteria that may have explained the pursuit of care
Analysis of patient criteria (age, comorbidities, etc.) that may have explained the continuation of care, treatments and paraclinical exams up to the last 24 hours before death.
Measured: In the last week of life and 24 hours before death
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Sep 2023
- Study start1 Mar 2024
- Primary completion31 Dec 2025 (estimated)
- Study completion31 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for End-of-life CareStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire de Saint EtienneThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Ludovic LAFAIE, MD, Principal investigator, Centre Hospitalier Universitaire de Saint Etienne
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06026241
- Sponsor's protocol ID
- IRBN1162023/CHUSTE
- Status last verified
- Mar 2025
- First submitted
- 30 Aug 2023
- Last updated
- 18 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Practice Analysis of Care, Paraclinical Exams and Treatments Received by Geriatric Patients Both During the Last Week and the Last 24 Hours of Their Lives.
- ClinicalTrials.gov ID
- NCT06026241
- Acronym / sponsor ID
- IRBN1162023/CHUSTE
- Conditions
- End-of-life Care
- Keywords
- End of life care, Geriatric, Death
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Centre Hospitalier Universitaire de Saint EtienneUniversity, hospital or other
- Study start
- 1 Mar 2024 (actual)
- Primary completion
- 31 Dec 2025 (estimated)
- Study completion
- 31 Dec 2025 (estimated)
- First posted
- 7 Sep 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
End-of-life care is a core topic for geriatricians. One of the key aspects of end-of-life management is deciding when to discontinue active care measures (for example blood pressure monitoring, blood tests and X-rays) in favor of exclusive comfort care. In this retrospective observational study, the investigators looked at the care measures, treatments and paraclinical exams received by geriatric patients both one week and 24 hours before their death.
Detailed description
This analysis provides information on the differences in geriatric physicians' practices regarding the anticipation of the end of life, by showing on average when active care measures were stopped before death. Secondly, the investigators looked at patient criteria that could explain a prolongation of active care and a delay in the implementation of exclusive comfort care.
Study design
- Observational model
- Other
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients over 75 who died in geriatrics | – | Other: Collecting data from the medical recordPatients over 75 years old who died in the geriatric short-stay departments of Saint-Etienne University Hospital |
Who may qualify
- Ages
- 75 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
- Study population
- All patients over 75 years old who died in the geriatric short-stay departments of Saint-Etienne University Hospital
Key inclusion criteria (1 listed)
- All patients over 75 years old who died in a geriatric short-stay department at Saint-Etienne University Hospital.
Key exclusion criteria (1 listed)
- Patients under 75 years old
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Collecting data from the medical recordPatient's socio-demographic data (age, gender, residence), comorbidities, cause of death, date and frequency of care measures/treatments/paraclinical exams received before their death. | Other | Patients over 75 who died in geriatrics |
Primary outcome
Prevalence of care and treatments received during the last week of life, and during the last 24 hours of life
Time frame: In the last week of life and 24 hours before death
To measure the prevalence of care (hemodynamic, biological and radiological monitoring), and to evaluate the treatments received during the last week of life, and during the last 24 hours of life of patients hospitalized and who died in a geriatric short-stay ward.
1 secondary outcome
Patient criteria that may have explained the pursuit of care
Time frame: In the last week of life and 24 hours before death
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Mar 2025.
- Individual participant dataSharing planned: No
Related trials for End-of-life Care
RecruitingPhase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Not yet recruitingObservational study
IN-TALK: Co-producing a Hospice Intimacy Support Toolkit in England
Communication About Intimacy Needs in Hospice and Palliative Care
RecruitingObservational study
Parastomal Hernia at 1 and 3 Years: Radiological Incidence, Progression, and Impact on Quality of Life
Parastomal Hernia, Colorectal Cancer (Diagnosis)
Not yet recruiting
Inpatient Hospice Transitions Checklist
Dementia
Not yet recruiting
Cycling During Dialysis: A Feasibility and Safety Study
Hemodialysis, Kidney Disease, End-Stage
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ludovic LAFAIE, MD principal investigator
Centre Hospitalier Universitaire de Saint Etienne
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of End-of-life Care, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 18 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Ludovic LAFAIE, MD ((0)477127397 ext. +33, ludovic.lafaie@chu-st-etienne.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of care and treatments received during the last week of life, and during the last 24 hours of life (time frame: In the last week of life and 24 hours before death). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2025.